BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15362580)

  • 1. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head.
    Hartel M; Niedergethmann M; Farag-Soliman M; Sturm JW; Richter A; Trede M; Post S
    Eur J Surg; 2002; 168(12):707-12. PubMed ID: 15362580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
    Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
    Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
    HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
    Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
    Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
    Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
    Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
    Yu XZ; Li J; Fu DL; Di Y; Yang F; Hao SJ; Jin C
    Eur J Surg Oncol; 2014 Apr; 40(4):371-8. PubMed ID: 24560302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thrombosis following pancreaticoduodenectomy with venous resection.
    Mohammed S; Mendez-Reyes JE; McElhany A; Gonzales-Luna D; Van Buren G; Bland DS; Villafane-Ferriol N; Pierzynski JA; West CA; Silberfein EJ; Fisher WE
    J Surg Res; 2018 Aug; 228():271-280. PubMed ID: 29907222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Welsch T; Degrate L; Zschäbitz S; Hofer S; Werner J; Schmidt J
    Langenbecks Arch Surg; 2011 Mar; 396(3):353-62. PubMed ID: 20336311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
    Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
    BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer.
    Jang JY; Kang MJ; Heo JS; Choi SH; Choi DW; Park SJ; Han SS; Yoon DS; Yu HC; Kang KJ; Kim SG; Kim SW
    Ann Surg; 2014 Apr; 259(4):656-64. PubMed ID: 24368638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
    Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
    Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.